Edwards Lifesciences Corporation Provides Earnings Guidance for the First Quarter and Full Year 2024
For full year 2024, the company expects sales to grow 8% to 10% to $6.3 billion to $6.6 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
87.42 USD | +2.74% | +2.77% | +14.65% |
1st Jan change | Capi. | |
---|---|---|
+14.65% | 51.28B | |
+8.88% | 219B | |
+8.68% | 185B | |
+14.25% | 135B | |
+28.18% | 107B | |
+4.48% | 51.01B | |
+4.39% | 41.85B | |
+7.00% | 37.02B | |
+26.06% | 31.27B | |
+16.53% | 23.66B |